Watch RXRX. Know when insiders buy.
One email the day a filing lands. Free.
RXRX
RECURSION PHARMACEUTICALS, INC.
3.72
+0.06 +1.78%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
39
FLAG · insiders 30, shorts 48
Insiders, 90 days
−$546K
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2BP/E —DIV YIELD —FCF YIELD -17.67%REV TTM $54.9M −15.1%NET INCOME −$518.9MNET CASH $545M52W 2.84 – 6.30NEXT EARNINGS Nov 4 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$546K
Net, 90 days
0 / 4
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 6 | Oct 7 | HERSHBERG ROBERT · Director | Sell | 25,000 | $5.00 | $125K |
| Oct 6 | Oct 7 | Borgeson Blake · Director | Sell | 50,000 | $4.84 | $242K |
| Sep 8 | Sep 10 | Khan Najat · CEO and President | Sell | 22,408 | $3.52 | $79K |
| Sep 1 | Sep 2 | Borgeson Blake · Director | Sell | 30,000 | $3.34 | $100K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.